We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.


26 March 2013 By Kevin Allison

Sharp falls in the stock price of London-listed ENRC and its 26 pct shareholder, Kazakhmys, may make the companies look cheap. But investors need to dig deep to see any value. ENRC’s iffy governance is only part of the problem. Operational and strategic questions are rife.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)